CeriBell, Inc. Increase (Decrease) in Accounts Receivable
CeriBell, Inc. (CBLL) reported Increase (Decrease) in Accounts Receivable of $942.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-10
- CeriBell, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $283.00K, a 72.06% decline year-over-year.
- CeriBell, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $659.00K, a 56.53% increase year-over-year.
- CeriBell, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $2.82M, a 211.49% increase year-over-year.
- CeriBell, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$78.00K, a 110.26% decline year-over-year.
- CeriBell, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $4.17M, a 42.83% increase from fiscal 2024.
- CeriBell, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $2.92M, a 9.89% increase from fiscal 2023.
- CeriBell, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $2.66M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $942.00K 10-Q · filed 2026-08-10 | $3.76M derived: sum of 3 quarters · filed 2026-08-10 | $3.68M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $659.00K 10-Q · filed 2026-05-11 | $3.48M derived: sum of 2 quarters · filed 2026-05-11 | $3.40M derived: sum of 3 quarters · filed 2026-05-11 | $4.41M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.74M derived: sum of 2 quarters · filed 2026-02-24 | $3.75M derived: sum of 3 quarters · filed 2026-08-10 | $4.17M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $935.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.36M 10-Q · filed 2025-11-04 | $2.26M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.43M 10-Q · filed 2026-08-10 | $2.34M derived: sum of 3 quarters · filed 2026-08-10 | $3.10M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $421.00K 10-Q · filed 2026-05-11 | $1.33M derived: sum of 2 quarters · filed 2026-05-11 | $2.09M derived: sum of 3 quarters · filed 2026-05-11 | $2.38M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $905.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.67M derived: sum of 2 quarters · filed 2026-02-24 | $1.96M derived: sum of 3 quarters · filed 2026-02-24 | $2.92M 10-K · filed 2026-02-24 |
| 2024-09-30 | $760.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.05M derived: sum of 2 quarters · filed 2025-11-04 | $2.02M 10-Q · filed 2025-11-04 | $3.10M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $291.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.26M 10-Q · filed 2025-08-05 | $2.34M derived: sum of 3 quarters · filed 2025-08-05 | |
| 2024-03-31 | $967.00K 10-Q · filed 2025-05-08 | $2.05M derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.66M 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $1.58M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |